Allergan Strikes $130M Deal Over Drug Price-Fixing Claims
Allergan has agreed to a $130 million settlement over class claims it took part in a generic-drug price-fixing scheme, investors said in seeking a New Jersey federal court's blessing for what...To view the full article, register now.
Already a subscriber? Click here to view full article